CD8A and cancer: The antigen-loaded iDCs are then stimulated by specific cytokines to maturate before injecting them back into the patient, where the mature DCs can present cancer antigens to CD4+/CD8+ T cells, inducing a sustained antitumor response [139,140,141,142,143].